New heart mapping tech tested for AFib treatment
NCT ID NCT06175234
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a new mapping feature (FARAVIEW™) used with a pulsed field ablation catheter (FARAWAVE NAV™) to treat atrial fibrillation. Fifty patients with symptomatic AFib that didn't respond to medication were included. The goal was to see how well doctors could isolate the pulmonary veins and how they rated the technology. The study is complete and focused on procedure success and user feedback.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FARAWAVE NAV pulsed field ablation catheter and FARAVIEW™ mapping technology
What this could lead to
If successful, this could improve how doctors treat atrial fibrillation by making ablation procedures more precise and easier to perform.
What could go wrong
This is a small, completed study focused on user experience, not long-term patient outcomes. The technology may not work better than existing methods, and there are standard risks like bleeding or heart damage from the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clínica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Mater Private Hospital
Dublin, 7 D07 RD8P, Ireland
-
Na Homolce Hospital
Prague, 15030, Czechia